1. Home
  2. CMCO vs APLT Comparison

CMCO vs APLT Comparison

Compare CMCO & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCO
  • APLT
  • Stock Information
  • Founded
  • CMCO 1875
  • APLT 2016
  • Country
  • CMCO United States
  • APLT United States
  • Employees
  • CMCO N/A
  • APLT N/A
  • Industry
  • CMCO Construction/Ag Equipment/Trucks
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCO Industrials
  • APLT Health Care
  • Exchange
  • CMCO Nasdaq
  • APLT Nasdaq
  • Market Cap
  • CMCO 472.4M
  • APLT 52.9M
  • IPO Year
  • CMCO 1996
  • APLT 2019
  • Fundamental
  • Price
  • CMCO $16.39
  • APLT $0.33
  • Analyst Decision
  • CMCO Hold
  • APLT Buy
  • Analyst Count
  • CMCO 1
  • APLT 7
  • Target Price
  • CMCO $35.00
  • APLT $6.10
  • AVG Volume (30 Days)
  • CMCO 365.8K
  • APLT 2.3M
  • Earning Date
  • CMCO 07-30-2025
  • APLT 08-06-2025
  • Dividend Yield
  • CMCO 1.71%
  • APLT N/A
  • EPS Growth
  • CMCO N/A
  • APLT N/A
  • EPS
  • CMCO N/A
  • APLT N/A
  • Revenue
  • CMCO $963,027,000.00
  • APLT $265,000.00
  • Revenue This Year
  • CMCO $10.17
  • APLT $1,768.13
  • Revenue Next Year
  • CMCO $33.08
  • APLT $292.85
  • P/E Ratio
  • CMCO N/A
  • APLT N/A
  • Revenue Growth
  • CMCO N/A
  • APLT N/A
  • 52 Week Low
  • CMCO $11.78
  • APLT $0.30
  • 52 Week High
  • CMCO $41.05
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • CMCO 58.61
  • APLT 46.71
  • Support Level
  • CMCO $15.02
  • APLT $0.30
  • Resistance Level
  • CMCO $15.65
  • APLT $0.36
  • Average True Range (ATR)
  • CMCO 0.60
  • APLT 0.03
  • MACD
  • CMCO 0.19
  • APLT 0.00
  • Stochastic Oscillator
  • CMCO 95.87
  • APLT 46.22

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: